From the Division of Neurology, Department of Medicine (J.D.S., J.R., C.J., F.L.S.).
Division of Neuroradiology, Department of Medical Imaging (S.R., J.M.C., D.J.M., D.M.M.), University Health Network, Toronto, Ontario, Canada.
AJNR Am J Neuroradiol. 2019 Oct;40(10):1701-1706. doi: 10.3174/ajnr.A6202. Epub 2019 Sep 5.
Secondary prevention of ischemic stroke depends on determining the cause of the initial ischemic event, but standard investigations often fail to identify a cause or identify multiple potential causes. The purpose of this study was to characterize the impact of intracranial vessel wall MR imaging on the etiologic classification of ischemic stroke.
This was a single-center, retrospective study of 205 consecutive patients who were referred for vessel wall MR imaging to clarify the etiology of an ischemic stroke or TIA. An expert panel classified stroke etiology before and after incorporating vessel wall MR imaging results using a modified Trial of Org 10172 in Acute Stroke Treatment system. We measured the proportion of patients with an altered etiologic classification after vessel wall MR imaging.
The median age was 56 years (interquartile range = 44-67 years), and 51% (106/205) of patients were men. Vessel wall MR imaging altered the etiologic classification in 55% (112/205) of patients. The proportion of patients classified as having intracranial arteriopathy not otherwise specified decreased from 31% to 4% (64/205 versus 9/205; < .001) and the proportion classified as having intracranial atherosclerotic disease increased from 23% to 57% (48/205 versus 116/205; < .001). Conventional work-up classification as intracranial arteriopathy not otherwise specified was an independent predictor of vessel wall MR imaging impact (OR = 8.9; 95% CI, 3.0-27.2). The time between symptom onset and vessel wall MR imaging was not a predictor of impact.
When vessel wall MR imaging is performed to clarify the etiology of a stroke or TIA, it frequently alters the etiologic classification. This is important because the etiologic classification is the basis for therapeutic decision-making.
缺血性脑卒中的二级预防取决于确定初始缺血事件的原因,但标准检查通常无法确定病因或确定多个潜在病因。本研究旨在描述颅内血管壁磁共振成像对缺血性脑卒中病因分类的影响。
这是一项单中心、回顾性研究,共纳入 205 例连续就诊患者,这些患者因缺血性卒中和 TIA 行血管壁磁共振成像以明确病因。采用改良组织型纤溶酶原激活剂治疗急性脑卒中试验病因分类系统,在纳入血管壁磁共振成像结果之前和之后,由专家小组对脑卒中病因进行分类。我们测量了血管壁磁共振成像后病因分类改变的患者比例。
患者中位年龄为 56 岁(四分位间距=44-67 岁),51%(106/205)为男性。血管壁磁共振成像改变了 55%(112/205)患者的病因分类。未特指颅内动脉病变的患者比例从 31%降至 4%(64/205 例比 9/205 例;<.001),颅内动脉粥样硬化性疾病的患者比例从 23%升至 57%(48/205 例比 116/205 例;<.001)。常规检查分类为未特指颅内动脉病变是血管壁磁共振成像影响的独立预测因素(OR=8.9;95%CI,3.0-27.2)。症状发作与血管壁磁共振成像之间的时间间隔不是影响的预测因素。
当为明确脑卒中或 TIA 的病因而行血管壁磁共振成像时,其常改变病因分类。这很重要,因为病因分类是治疗决策的基础。